Entering text into the input field will update the search result below

FDA OKs Abbott's HeartMate 3 LVAD

Oct. 19, 2018 9:20 AM ETAbbott Laboratories (ABT) StockBy: Douglas W. House, SA News Editor
  • The FDA approves Abbott's (NYSE:ABT) HeartMate 3 Left Ventricular Assist Device (LVAD) as a destination therapy in patients with advanced heart failure. Doctors can now prescribe the device for patients not eligible for transplant who will have the device for the remainder of their lives.
  • Shares are up a fraction premarket.

Recommended For You

More Trending News

About ABT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ABT--
Abbott Laboratories